163 related articles for article (PubMed ID: 23510323)
1. Heat-shock factor 1 both positively and negatively affects cellular clonogenic growth depending on p53 status.
Nguyen CH; Lang BJ; Chai RC; Vieusseux JL; Kouspou MM; Price JT
Biochem J; 2013 Jun; 452(2):321-9. PubMed ID: 23510323
[TBL] [Abstract][Full Text] [Related]
2. Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors.
Min JN; Huang L; Zimonjic DB; Moskophidis D; Mivechi NF
Oncogene; 2007 Aug; 26(35):5086-97. PubMed ID: 17310987
[TBL] [Abstract][Full Text] [Related]
3. The p53 tumor suppressor gene and gene product.
Levine AJ
Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
[TBL] [Abstract][Full Text] [Related]
4. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
[TBL] [Abstract][Full Text] [Related]
5. Targeting the heat shock factor 1 by RNA interference: a potent tool to enhance hyperthermochemotherapy efficacy in cervical cancer.
Rossi A; Ciafrè S; Balsamo M; Pierimarchi P; Santoro MG
Cancer Res; 2006 Aug; 66(15):7678-85. PubMed ID: 16885369
[TBL] [Abstract][Full Text] [Related]
6. Roles of heat shock factor 1 and 2 in response to proteasome inhibition: consequence on p53 stability.
Lecomte S; Desmots F; Le Masson F; Le Goff P; Michel D; Christians ES; Le Dréan Y
Oncogene; 2010 Jul; 29(29):4216-24. PubMed ID: 20498630
[TBL] [Abstract][Full Text] [Related]
7. Active heat shock transcription factor 1 supports migration of the melanoma cells via vinculin down-regulation.
Toma-Jonik A; Widlak W; Korfanty J; Cichon T; Smolarczyk R; Gogler-Piglowska A; Widlak P; Vydra N
Cell Signal; 2015 Feb; 27(2):394-401. PubMed ID: 25435429
[TBL] [Abstract][Full Text] [Related]
8. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
[TBL] [Abstract][Full Text] [Related]
9. Mouse heat-shock factor 1 (HSF1) is involved in testicular response to genotoxic stress induced by doxorubicin.
Salmand PA; Jungas T; Fernandez M; Conter A; Christians ES
Biol Reprod; 2008 Dec; 79(6):1092-101. PubMed ID: 18703420
[TBL] [Abstract][Full Text] [Related]
10. Ha-ras(val12) induces HSP70b transcription via the HSE/HSF1 system, but HSP70b expression is suppressed in Ha-ras(val12)-transformed cells.
Stanhill A; Levin V; Hendel A; Shachar I; Kazanov D; Arber N; Kaminski N; Engelberg D
Oncogene; 2006 Mar; 25(10):1485-95. PubMed ID: 16278678
[TBL] [Abstract][Full Text] [Related]
11. Function of Hsf1 in SV40 T‑antigen‑transformed HEK293T cells.
Jiang Q; Zhang Z; Hu Y; Ma Y
Mol Med Rep; 2014 Dec; 10(6):3139-44. PubMed ID: 25310819
[TBL] [Abstract][Full Text] [Related]
12. Heat shock factor 1 in protein homeostasis and oncogenic signal integration.
Home T; Jensen RA; Rao R
Cancer Res; 2015 Mar; 75(6):907-12. PubMed ID: 25724679
[TBL] [Abstract][Full Text] [Related]
13. p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis.
de Belle I; Huang RP; Fan Y; Liu C; Mercola D; Adamson ED
Oncogene; 1999 Jun; 18(24):3633-42. PubMed ID: 10380885
[TBL] [Abstract][Full Text] [Related]
14. Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage.
Aloni-Grinstein R; Zan-Bar I; Alboum I; Goldfinger N; Rotter V
Oncogene; 1993 Dec; 8(12):3297-305. PubMed ID: 8247532
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.
Zhao YH; Zhou M; Liu H; Ding Y; Khong HT; Yu D; Fodstad O; Tan M
Oncogene; 2009 Oct; 28(42):3689-701. PubMed ID: 19668225
[TBL] [Abstract][Full Text] [Related]
16. Heat shock factor 1-mediated aneuploidy requires a defective function of p53.
Kim EH; Lee YJ; Bae S; Lee JS; Kim J; Lee YS
Cancer Res; 2009 Dec; 69(24):9404-12. PubMed ID: 19934326
[TBL] [Abstract][Full Text] [Related]
17. The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma.
Heimberger T; Andrulis M; Riedel S; Stühmer T; Schraud H; Beilhack A; Bumm T; Bogen B; Einsele H; Bargou RC; Chatterjee M
Br J Haematol; 2013 Feb; 160(4):465-76. PubMed ID: 23252346
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of wild-type p53-mediated transactivation is insufficient for mutant p53-induced immortalization of normal human mammary epithelial cells.
Cao Y; Gao Q; Wazer DE; Band V
Cancer Res; 1997 Dec; 57(24):5584-9. PubMed ID: 9407971
[TBL] [Abstract][Full Text] [Related]
19. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.
Hinds PW; Finlay CA; Quartin RS; Baker SJ; Fearon ER; Vogelstein B; Levine AJ
Cell Growth Differ; 1990 Dec; 1(12):571-80. PubMed ID: 2288874
[TBL] [Abstract][Full Text] [Related]
20. Hsf4 counteracts Hsf1 transcription activities and increases lens epithelial cell survival in vitro.
Cui X; Xie PP; Jia PP; Lou Q; Dun G; Li S; Liu G; Zhang J; Dong Z; Ma Y; Hu Y
Biochim Biophys Acta; 2015 Mar; 1853(3):746-55. PubMed ID: 25601714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
